TCL Archive In Brief: Peter Greenwald A Leading Candidate For One Of Three Top NCI Jobs Remaining To Be Filled August 7, 1981
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006